The Global Health Body Issues Alert Over Critical Lack of Obesity Medications
Less than 10% of people that would benefit from obesity jabs including Wegovy can access them, states the global health agency as it publishes its initial advice on the drugs.
Considering in excess of 1,000,000,000 people worldwide now classified as obese, it is urging increased and just availability to GLP-1 medication.
Per estimates, over two billion are projected to be obese by 2030 unless action is taken.
"Our latest guidance recognises that obesity is a chronic disease that can be treated with holistic and lifelong support," said the agency's head Tedros Adhanom Ghebreyesus.
High costs, constrained manufacturing, and distribution challenges are major hurdles to widespread access to the injections that can aid individuals in losing substantial weight, explains the body.
Skinny Jab Supply Crisis
Even under the current best projected outlook, the manufacturing of GLP-1 therapies would only suffice for around 100 million people – under 10% of eligible patients, per the health organization.
The recommendation calls on governments and firms to increase availability, via strategies including voluntary licensing.
The intellectual property rights on the active ingredient – the primary ingredient of a leading brand – is scheduled to end in multiple countries in 2026.
How Weight-Loss Injections Operate
The injections mimick a body's own hormone to delay gastric emptying, curb appetite and enhance feelings of fullness so individuals consume fewer calories.
Individuals commonly see weight reduction after several weeks of commencing the weekly injections.
Research indicates users may regain a significant portion after a year of discontinuing the treatment, because their typical appetite come back.
To be overweight or obese raises your likelihood for contracting medical conditions, such as type 2 diabetes, cardiovascular issues, stroke, and some malignancies.
Excess weight impacts individuals in countries worldwide and was linked to millions of fatalities worldwide in 2024, as per the WHO.
